TERC and cancer: Double null SCC exhibited severe depletion of this cancer stem cell population (3.5% vs. 0.7%; P < 0.009; Figure 5P, 5Q) which was significantly greater than that observed in Terc null (3.3%) and TRF2 null (0.9%) tumors (Supplementary Figure 3H, I).